Notably, the overexpression of miR-338-5p inhibited the level of phosphorylated EGFR and ERK1/2, and P-gp expression was suppressed after the inhibition of ERK1/2 phosphorylation in HCC cells. The gene discussed is MAPK3; the disease is hepatocellular carcinoma.